|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
TNGX | Crystal Adam | See Remarks | Feb 06 | Sale | 12.56 | 4,288 | 53,868 | 123,561 | Feb 08 09:04 PM |
TNGX | Crystal Adam | See Remarks | Feb 07 | Sale | 12.62 | 4,083 | 51,527 | 119,478 | Feb 08 09:04 PM |
TNGX | Crystal Adam | See Remarks | Nov 01 | Sale | 8.39 | 7,507 | 62,994 | 81,250 | Nov 02 04:49 PM |
CCCC | Crystal Adam | Chief Medical Officer | Jan 04 | Option Exercise | 6.49 | 15,000 | 97,350 | 30,000 | Jan 05 04:30 PM |
CCCC | Crystal Adam | Chief Medical Officer | Jan 04 | Sale | 31.66 | 15,000 | 474,968 | 15,000 | Jan 05 04:30 PM |
CCCC | Crystal Adam | Chief Medical Officer | Dec 22 | Option Exercise | 6.49 | 5,000 | 32,450 | 15,000 | Dec 23 04:10 PM |
CCCC | Crystal Adam | Chief Medical Officer | Oct 08 | Option Exercise | 6.49 | 10,000 | 64,900 | 10,000 | Oct 12 04:30 PM |
CCCC | Crystal Adam | Chief Medical Officer | Oct 01 | Option Exercise | 4.98 | 15,000 | 74,700 | 15,000 | Oct 05 04:53 PM |
CCCC | Crystal Adam | Chief Medical Officer | Oct 01 | Sale | 45.43 | 15,000 | 681,438 | 0 | Oct 05 04:53 PM |
CCCC | Crystal Adam | Chief Medical Officer | Jul 29 | Option Exercise | 4.98 | 15,000 | 74,700 | 15,000 | Aug 02 06:44 PM |
CCCC | Crystal Adam | Chief Medical Officer | Jul 29 | Sale | 45.00 | 15,000 | 675,000 | 0 | Aug 02 06:44 PM |
CCCC | Crystal Adam | Chief Medical Officer | Jul 01 | Option Exercise | 6.50 | 15,000 | 97,500 | 15,000 | Jul 06 08:00 PM |
CCCC | Crystal Adam | Chief Medical Officer | Jul 01 | Sale | 37.98 | 15,000 | 569,666 | 0 | Jul 06 08:00 PM |
CCCC | Crystal Adam | Chief Medical Officer | Apr 05 | Option Exercise | 6.50 | 15,000 | 97,500 | 15,000 | Apr 06 04:30 PM |
CCCC | Crystal Adam | Chief Medical Officer | Apr 05 | Sale | 37.77 | 15,000 | 566,536 | 0 | Apr 06 04:30 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite